Alnylam price target raised to $295 from $215 at Stifel

Stifel raised the firm’s price target on Alnylam to $295 from $215 and keeps a Buy rating on the shares. While there are still a few key HELIOS-B questions that are yet to be answered, this result is an outstanding outcome for Alnylam, the analyst tells investors in a research note. This implies a $5-$6B opportunity, as the company advances nine additional INDs by year-end 2025, the firm says.